High levels of MyD88 protein expression were confirmed in hormone-resistant breast cancer cell lines MDA-MB-231, MDA-MB-231HM, and MDA-MB-468, whereas such confirmation was not observed in MCF-7 and SKBR3 cell lines. Here, MYD88 is linked to breast cancer.